U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 1596

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr1:216348812
GRCh38:
Chr1:216175470
USH2AL1470fsUsher syndrome type 2ALikely pathogenic
(Sep 12, 2023)
criteria provided, single submitter
2.
GRCh38:
Chr1:216190126-216251196
LOC122152296, LOC132088648, USH2A, USH2A-AS1Usher syndrome type 2ALikely pathogenic
(Aug 24, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr1:215847736-215847737
GRCh38:
Chr1:215674394-215674395
USH2AS4506fsUsher syndrome type 2APathogenic
(Jun 26, 2023)
no assertion criteria provided
4.
GRCh37:
Chr1:216138660-216270555
USH2AUsher syndrome type 2APathogenic
(May 26, 2023)
criteria provided, single submitter
5.
GRCh37:
Chr8:22021421
GRCh38:
Chr8:22163908
SFTPCP101L, P148L, P154LUsher syndrome type 2AUncertain significance
(Jul 22, 2020)
criteria provided, single submitter
6.
GRCh37:
Chr1:215987118
GRCh38:
Chr1:215813776
USH2AH3234fsUsher syndrome type 2APathogenic
(Feb 28, 2023)
criteria provided, single submitter
7.
GRCh37:
Chr1:216256904-216256905
GRCh38:
Chr1:216083562-216083563
USH2A-AS2, USH2AM1731fsUsher syndrome type 2APathogenic
(Feb 23, 2023)
criteria provided, single submitter
8.
GRCh37:
Chr1:215916617
GRCh38:
Chr1:215743275
USH2AT3817IUsher syndrome type 2AUncertain significance
(Dec 15, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr1:216138732
GRCh38:
Chr1:215965390
USH2AW2349*Usher syndrome type 2APathogenic
(Jan 25, 2023)
criteria provided, single submitter
10.
GRCh37:
Chr1:216420569
GRCh38:
Chr1:216247227
USH2AUsher syndrome type 2ALikely pathogenic
(Oct 28, 2021)
criteria provided, single submitter
11.
GRCh37:
Chr1:216496897
GRCh38:
Chr1:216323555
USH2AH490PUsher syndrome type 2AUncertain significance
(May 6, 2021)
criteria provided, single submitter
12.
GRCh37:
Chr1:216498937-216498940
GRCh38:
Chr1:216325595-216325598
USH2AUsher syndrome type 2APathogenic
(May 6, 2021)
criteria provided, single submitter
13.
USH2AUsher syndrome type 2APathogenic
(Nov 10, 2022)
criteria provided, single submitter
14.
GRCh38:
Chr1:216462679-216462739
USH2AUsher syndrome type 2ALikely pathogenic
(Nov 10, 2022)
criteria provided, single submitter
15.
GRCh38:
Chr1:216108034-216108100
USH2AUsher syndrome type 2ALikely pathogenic
(Nov 10, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr1:216465714
GRCh38:
Chr1:216292372
USH2AUsher syndrome type 2A, not providedPathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr1:216144093
GRCh38:
Chr1:215970751
USH2AY2277*Usher syndrome type 2ALikely pathogenic
(Jan 2, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr1:216420006-216420007
GRCh38:
Chr1:216246664-216246665
LOC122152296, USH2AG910fsUsher syndrome type 2ALikely pathogenic
(Jan 2, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr1:215847771
GRCh38:
Chr1:215674429
USH2AY4494*Usher syndrome type 2ALikely pathogenic
(Jan 2, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr1:216496971-216496972
GRCh38:
Chr1:216323629-216323630
USH2AP465fsUsher syndrome type 2ALikely pathogenic
(Jan 2, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr1:216496866-216496867
GRCh38:
Chr1:216323524-216323525
USH2AV500fsUsher syndrome type 2ALikely pathogenic
(Dec 31, 2021)
criteria provided, single submitter
22.
GRCh37:
Chr1:216373295-216373296
GRCh38:
Chr1:216199953-216199954
USH2A, USH2A-AS1S1162fsUsher syndrome type 2ALikely pathogenic
(Dec 30, 2021)
criteria provided, single submitter
23.
GRCh37:
Chr1:216420467
GRCh38:
Chr1:216247125
USH2AK757*Usher syndrome type 2ALikely pathogenic
(Dec 29, 2021)
criteria provided, single submitter
24.
GRCh37:
Chr1:216420211
GRCh38:
Chr1:216246869
LOC122152296, USH2AF842fsUsher syndrome type 2ALikely pathogenic
(Dec 17, 2021)
criteria provided, single submitter
25.
GRCh37:
Chr1:216246257
GRCh38:
Chr1:216072915
USH2A, USH2A-AS2W1944*Usher syndrome type 2ALikely pathogenic
(Dec 16, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr1:216497662-216497668
GRCh38:
Chr1:216324320-216324326
USH2AS391fsUsher syndrome type 2ALikely pathogenic
(May 30, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr1:216221983
GRCh38:
Chr1:216048641
USH2AL2019*Usher syndrome type 2ALikely pathogenic
(May 24, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr1:215820994
GRCh38:
Chr1:215647652
USH2AY4887*Usher syndrome type 2ALikely pathogenic
(May 11, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr1:216497603
GRCh38:
Chr1:216324261
USH2AW412*Usher syndrome type 2ALikely pathogenic
(May 8, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr1:216500988
GRCh38:
Chr1:216327646
USH2AQ265*Usher syndrome type 2ALikely pathogenic
(Apr 12, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr1:216498775-216498776
GRCh38:
Chr1:216325433-216325434
USH2AA339fsUsher syndrome type 2ALikely pathogenic
(Apr 10, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr1:216372969
GRCh38:
Chr1:216199627
USH2A, USH2A-AS1G1271*Usher syndrome type 2ALikely pathogenic
(Apr 6, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr1:216051113
GRCh38:
Chr1:215877771
USH2AK2890*Usher syndrome type 2ALikely pathogenic
(Apr 4, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr1:216390805
GRCh38:
Chr1:216217463
USH2A, USH2A-AS1T1028fsUsher syndrome type 2ALikely pathogenic
(Mar 31, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr1:216373448
GRCh38:
Chr1:216200106
USH2A, USH2A-AS1L1111*Usher syndrome type 2ALikely pathogenic
(Mar 31, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr1:216420311-216420313
GRCh38:
Chr1:216246969-216246971
LOC122152296, USH2AC808fsUsher syndrome type 2ALikely pathogenic
(Mar 30, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr1:216496937-216496938
GRCh38:
Chr1:216323595-216323596
USH2AQ477fsUsher syndrome type 2ALikely pathogenic
(Mar 30, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr1:216420359
GRCh38:
Chr1:216247017
LOC122152296, USH2AK793*Usher syndrome type 2ALikely pathogenic
(Mar 30, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr1:216373157
GRCh38:
Chr1:216199815
USH2A, USH2A-AS1W1208*Usher syndrome type 2ALikely pathogenic
(Mar 30, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr1:216061809
GRCh38:
Chr1:215888467
USH2AQ2728*Usher syndrome type 2ALikely pathogenic
(Mar 30, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr1:216420419
GRCh38:
Chr1:216247077
LOC122152296, USH2AK773*Usher syndrome type 2ALikely pathogenic
(Mar 30, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr1:215914802
GRCh38:
Chr1:215741460
USH2AK3876*Usher syndrome type 2ALikely pathogenic
(Mar 30, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr1:215848292
GRCh38:
Chr1:215674950
USH2AE4321*Usher syndrome type 2ALikely pathogenic
(Mar 29, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr1:216424418
GRCh38:
Chr1:216251076
USH2AK665fsUsher syndrome type 2ALikely pathogenic
(Mar 27, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr1:216371839-216371846
GRCh38:
Chr1:216198497-216198504
USH2A, USH2A-AS1Q1298fsUsher syndrome type 2ALikely pathogenic
(Mar 17, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr1:215847607
GRCh38:
Chr1:215674265
USH2AL4549*Usher syndrome type 2ALikely pathogenic
(Mar 15, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr1:216465698
GRCh38:
Chr1:216292356
USH2AL553fsUsher syndrome type 2ALikely pathogenic
(Mar 15, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr1:216498792-216498793
GRCh38:
Chr1:216325450-216325451
USH2AS333fsUsher syndrome type 2ALikely pathogenic
(Mar 14, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr1:215956085
GRCh38:
Chr1:215782743
USH2AS3527*Usher syndrome type 2ALikely pathogenic
(Mar 11, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr1:216420285
GRCh38:
Chr1:216246943
LOC122152296, USH2AC817*Usher syndrome type 2ALikely pathogenic
(Mar 11, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr1:216373094-216373095
GRCh38:
Chr1:216199752-216199753
USH2A, USH2A-AS1L1229fsUsher syndrome type 2ALikely pathogenic
(Mar 9, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr1:216538344-216538345
GRCh38:
Chr1:216365002-216365003
USH2AS245fsUsher syndrome type 2ALikely pathogenic
(Mar 8, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr1:215987210
GRCh38:
Chr1:215813868
USH2AG3203*Usher syndrome type 2ALikely pathogenic
(Mar 5, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr1:215847806
GRCh38:
Chr1:215674464
USH2AG4483*Usher syndrome type 2ALikely pathogenic
(Mar 4, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr1:216019166
GRCh38:
Chr1:215845824
USH2AE3019*Usher syndrome type 2ALikely pathogenic
(Mar 2, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr1:216052361
GRCh38:
Chr1:215879019
USH2AL2768*Usher syndrome type 2ALikely pathogenic
(Mar 2, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr1:215956179
GRCh38:
Chr1:215782837
USH2AE3496*Usher syndrome type 2ALikely pathogenic
(Feb 27, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr1:216373262-216373263
GRCh38:
Chr1:216199920-216199921
USH2A, USH2A-AS1S1173fsUsher syndrome type 2ALikely pathogenic
(Feb 25, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr1:216498834
GRCh38:
Chr1:216325492
USH2AC319fsUsher syndrome type 2ALikely pathogenic
(Feb 25, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr1:216369939-216369940
GRCh38:
Chr1:216196597-216196598
USH2A, USH2A-AS1S1403fsUsher syndrome type 2ALikely pathogenic
(Feb 22, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr1:216420319-216420320
GRCh38:
Chr1:216246977-216246978
LOC122152296, USH2AT806fsUsher syndrome type 2ALikely pathogenic
(Feb 22, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr1:215953281
GRCh38:
Chr1:215779939
USH2AK3615*Usher syndrome type 2ALikely pathogenic
(Feb 19, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr1:215990530
GRCh38:
Chr1:215817188
USH2AQ3127*Usher syndrome type 2ALikely pathogenic
(Feb 17, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr1:216405439-216405442
GRCh38:
Chr1:216232097-216232100
USH2A, USH2A-AS1L949fsUsher syndrome type 2ALikely pathogenic
(Feb 2, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr1:216538421
GRCh38:
Chr1:216365079
USH2AQ220*Usher syndrome type 2ALikely pathogenic
(Feb 2, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr1:216270532
GRCh38:
Chr1:216097190
USH2AK1551*Usher syndrome type 2ALikely pathogenic
(Feb 2, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr1:216405324-216405326
GRCh38:
Chr1:216231982-216231984
USH2A, USH2A-AS1H988fsUsher syndrome type 2ALikely pathogenic
(Jan 28, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr1:216052431
GRCh38:
Chr1:215879089
USH2AK2745*Usher syndrome type 2ALikely pathogenic
(Jan 28, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr1:216405411-216405412
GRCh38:
Chr1:216232069-216232070
USH2A, USH2A-AS1V959fsUsher syndrome type 2ALikely pathogenic
(Jan 27, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr1:216390811-216390814
GRCh38:
Chr1:216217469-216217472
USH2A, USH2A-AS1K1024fsUsher syndrome type 2ALikely pathogenic
(Jan 27, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr1:215848260
GRCh38:
Chr1:215674918
USH2AY4331*Usher syndrome type 2ALikely pathogenic
(Jan 25, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr1:216420267-216420268
GRCh38:
Chr1:216246925-216246926
LOC122152296, USH2AR824fsUsher syndrome type 2ALikely pathogenic
(Jan 25, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr1:216420053
GRCh38:
Chr1:216246711
LOC122152296, USH2AQ895*Usher syndrome type 2ALikely pathogenic
(Jan 24, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr1:216371738
GRCh38:
Chr1:216198396
USH2A, USH2A-AS1K1334*Usher syndrome type 2ALikely pathogenic
(Jan 24, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr1:216243590
GRCh38:
Chr1:216070248
USH2AG1968*Usher syndrome type 2ALikely pathogenic
(Nov 3, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr1:215933134
GRCh38:
Chr1:215759792
USH2AL3700*Usher syndrome type 2ALikely pathogenic
(Jan 23, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr1:216496927-216496931
GRCh38:
Chr1:216323585-216323589
USH2AF479fsUsher syndrome type 2ALikely pathogenic
(Jan 17, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr1:215847952
GRCh38:
Chr1:215674610
USH2AS4434*Usher syndrome type 2ALikely pathogenic
(Dec 21, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr1:216390803-216390804
GRCh38:
Chr1:216217461-216217462
USH2A, USH2A-AS1T1028fsUsher syndrome type 2ALikely pathogenic
(Jan 11, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr1:216019361
GRCh38:
Chr1:215846019
USH2AQ2954*Usher syndrome type 2ALikely pathogenic
(Jan 9, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr1:216371901
GRCh38:
Chr1:216198559
USH2A, USH2A-AS1Usher syndrome type 2APathogenic
(Oct 19, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr1:216380774
GRCh38:
Chr1:216207432
USH2A, USH2A-AS1Usher syndrome type 2ALikely pathogenic
(May 9, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr1:216061850
GRCh38:
Chr1:215888508
USH2AW2714*Usher syndrome type 2APathogenic
(Sep 1, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr1:216592023
GRCh38:
Chr1:216418681
USH2AUsher syndrome type 2ALikely pathogenic
(Sep 1, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr1:215848545
GRCh38:
Chr1:215675203
USH2AC4236*Usher syndrome type 2APathogenic
(Sep 1, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr1:216595277-216595278
GRCh38:
Chr1:216421935-216421936
USH2AS134fsUsher syndrome type 2APathogenic
(Sep 2, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr1:215820972
GRCh38:
Chr1:215647630
USH2AS4895GUsher syndrome type 2AUncertain significance
(May 2, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr1:216052184
GRCh38:
Chr1:215878842
USH2AL2827*Usher syndrome type 2ALikely pathogenic
(Mar 11, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr1:216262382
GRCh38:
Chr1:216089040
USH2AQ1620*Usher syndrome type 2ALikely pathogenic
(May 22, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr1:215814033
GRCh38:
Chr1:215640691
USH2AV4946fsUsher syndrome type 2APathogenic
(May 22, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr1:215847941
GRCh38:
Chr1:215674599
USH2AW4438Rnot specified, Retinitis pigmentosa 39, Usher syndrome type 2A
Uncertain significance
(Mar 18, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr1:216371804
GRCh38:
Chr1:216198462
USH2A, USH2A-AS1A1312fsUsher syndrome type 2APathogenic
(Oct 5, 2020)
criteria provided, single submitter
93.
GRCh37:
Chr1:216270450
GRCh38:
Chr1:216097108
USH2AR1578HRetinitis pigmentosa 39, Usher syndrome type 2A, not provided
Uncertain significance
(Jul 2, 2023)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr1:215848937
GRCh38:
Chr1:215675595
USH2AG4106RUsher syndrome type 2A, Retinitis pigmentosa 39, not provided
Uncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr1:216363657
GRCh38:
Chr1:216190315
USH2AK1435TUsher syndrome type 2A, Retinitis pigmentosa 39, not provided
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
96.
GRCh37:
Chr1:215960134
GRCh38:
Chr1:215786792
USH2AS3422NUsher syndrome type 2A, not providedUncertain significance
(Dec 15, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr1:215933027
GRCh38:
Chr1:215759685
USH2AD3736Nnot provided, Retinitis pigmentosa 39, Usher syndrome type 2A
Uncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr10:102783795
GRCh38:
Chr10:101024038
PDZD7S86LUsher syndrome type 2C, Usher syndrome type 2A, Hearing loss, autosomal recessive 57,
not provided
Uncertain significance
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr1:216143966
GRCh38:
Chr1:215970624
USH2ARetinitis pigmentosa 39, Usher syndrome type 2A, not provided
Likely pathogenic
(Jul 28, 2021)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr1:215972394
GRCh38:
Chr1:215799052
USH2AM3271IUsher syndrome type 2A, Retinitis pigmentosa 39, not provided
Uncertain significance
(Aug 11, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination